Study finds more reliable rapid tests for Covid-19 – Times of India

WASHINGTON: During a recent study, researchers at the University of Maryland School of Medicine (UMSOM) developed two rapid diagnostic tests for Covid-19 that are nearly as accurate as the gold-standard test currently used in laboratories. Unlike the gold standard test, which extracts RNA and uses it to amplify the DNA of the virus, these new … Read more

FDA rejects emergency use authorisation for Covaxin in a setback for India-made jab

Hyderabad: In a setback to Bharat Biotech’s COVID-19 vaccine Covaxin, the US Food and Drug Administration has “recommended” Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixinghopes of Emergency Use Authorisation. Ocugen in a statement on Thursday announced that as recommended by … Read more

COVID jabs for kids aged 2 to 11: Pfizer to seek approval in Sept

Washington: Pharmaceutical major Pfizer will likely seek the US Food and Drug Administration’s emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, the media reported. By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 … Read more

US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week

Washington: The US Food and Drug Administration (FDA) is planning to open Pfizer-BioNTech coronavirus vaccine for adolescents aged 12 to 15 years by early next week, according to federal officials, the media reported. The FDA authorisation would be a welcome news to parents anxious to protect their children, The New York Times reported. Earlier in … Read more

COVID oral pill could be ready by year-end: Pfizer CEO

New York: US-based pharmaceutical major Pfizer’s Chief Executive Officer Albert Bourla said that the company’s COVID-19 oral antiviral pill, which is in early-stage trials, could be ready by the end of the year, the media reported. According to CNBC, the company, which developed the first authorised COVID-19 vaccine in the US with German drugmaker BioNTech, … Read more

Covid-19: US diverting raw material to Serum Institute for vaccine production | India News – Times of India

WASHINGTON: The United States on Monday rolled out a series of supportive measures to help India’s titanic fight against the Covid-19 upsurge, including diverting raw material to the Serum Institute to India to manufacture vaccines, and rushing oxygen generating systems and the drug Remdesivir, even as President Biden pledged America’s full support to provide emergency … Read more

In US, millions skipping their second doses of Covid vaccines – Times of India

Millions of Americans are not getting the second doses of their Covid-19 vaccines, and their ranks are growing. More than five million people, or nearly 8% of those who got a first shot of the Pfizer or Moderna vaccines, have missed their second doses, according to the most recent data from the Centers for Disease … Read more

BJP pressurising cops: Maharashtra home minister on pharma firm remdesivir stock | India News – Times of India

MUMBAI: Maharashtra home minister Dilip Walse Patil on Sunday accused the BJP of trying to pressurise the Mumbai police and interfere in their work, and warned that such attempts will not be tolerated. Talking to reporters, he said the city police had received a specific input that 50,000 vials of remdesivir were being brought to … Read more

This AI Could Help Wipe Out Colon Cancer

Michael Wallace has performed hundreds of colonoscopies in his 20 years as a gastroenterologist. He thinks he’s pretty good at recognizing the growths, or polyps, that can spring up along the ridges of the colon and potentially turn into cancer. But he isn’t always perfect. Sometimes the polyps are flat and hard to see. Other … Read more

Pfizer begins early-stage study of oral drug to combat coronavirus

Pfizer Inc has started an early-stage U.S. trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday. The drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany’s BioNTech SA, said the antiviral candidate showed potent activity against … Read more